questionsmedicales.fr
Facteurs biologiques
Antigènes
Superantigènes
Superantigènes : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Infections bactériennes
Anticorps
Tests diagnostiques
Culture bactérienne
Symptômes
Diagnostic différentiel
Allergies
Tests d'allergie
Symptômes
5
Choc toxique
Éruption cutanée
Symptômes neurologiques
Céphalée
Souches bactériennes
Variabilité des symptômes
Temps d'apparition
Exposition
Prévention
5
Prévention des infections
Hygiène
Sécurité alimentaire
Contamination
Mesures d'hygiène
Pratiques préventives
Milieu hospitalier
Désinfection
Traitements
5
Corticostéroïdes
Inflammation
Hospitalisation
Choc toxique
Traitement symptomatique
Antipyrétiques
Traitement spécifique
Superantigènes
Complications
5
Lésions organiques
Insuffisance rénale
Récidive
Facteurs de risque
Immunodépression
Complications
Développement rapide
Complications
Facteurs de risque
5
Immunodépression
Interventions chirurgicales
Enfants
Système immunitaire
Antécédents médicaux
Infections
Conditions de vie
Insalubrité
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Superantigènes : Questions médicales les plus fréquentes",
"headline": "Superantigènes : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Superantigènes : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-25",
"dateModified": "2025-03-20",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Superantigènes"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Antigènes",
"url": "https://questionsmedicales.fr/mesh/D000941",
"about": {
"@type": "MedicalCondition",
"name": "Antigènes",
"code": {
"@type": "MedicalCode",
"code": "D000941",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.050"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Antigènes mineurs de stimulation lymphocytaire",
"alternateName": "Minor Lymphocyte Stimulatory Antigens",
"url": "https://questionsmedicales.fr/mesh/D016747",
"about": {
"@type": "MedicalCondition",
"name": "Antigènes mineurs de stimulation lymphocytaire",
"code": {
"@type": "MedicalCode",
"code": "D016747",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.050.820.625"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Superantigènes",
"alternateName": "Superantigens",
"code": {
"@type": "MedicalCode",
"code": "D018089",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Mary Hongying Cheng",
"url": "https://questionsmedicales.fr/author/Mary%20Hongying%20Cheng",
"affiliation": {
"@type": "Organization",
"name": "Department of Computational and Systems Biology, School of Medicine, University of Pittsburgh, Pittsburgh, PA 15261."
}
},
{
"@type": "Person",
"name": "Rebecca A Porritt",
"url": "https://questionsmedicales.fr/author/Rebecca%20A%20Porritt",
"affiliation": {
"@type": "Organization",
"name": "Department of Pediatrics, Division of Pediatric Infectious Diseases and Immunology, Cedars-Sinai Medical Center, Los Angeles, CA 90048."
}
},
{
"@type": "Person",
"name": "Moshe Arditi",
"url": "https://questionsmedicales.fr/author/Moshe%20Arditi",
"affiliation": {
"@type": "Organization",
"name": "Department of Pediatrics, Division of Pediatric Infectious Diseases and Immunology, Cedars-Sinai Medical Center, Los Angeles, CA 90048."
}
},
{
"@type": "Person",
"name": "Ivet Bahar",
"url": "https://questionsmedicales.fr/author/Ivet%20Bahar",
"affiliation": {
"@type": "Organization",
"name": "Department of Computational and Systems Biology, School of Medicine, University of Pittsburgh, Pittsburgh, PA 15261."
}
},
{
"@type": "Person",
"name": "Samuel Ken-En Gan",
"url": "https://questionsmedicales.fr/author/Samuel%20Ken-En%20Gan",
"affiliation": {
"@type": "Organization",
"name": "Antibody & Product Development Lab, Experimental Drug Development Centre - Bioinformatics Institute (EDDC-BII), Agency for Science Technology and Research (ASTAR), Singapore, Singapore."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Depression circuit adaptation in post-stroke depression.",
"datePublished": "2023-05-17",
"url": "https://questionsmedicales.fr/article/37201899",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jad.2023.05.016"
}
},
{
"@type": "ScholarlyArticle",
"name": "Dissecting the depressed mood criterion in adult depression: The heterogeneity of mood disturbances in major depressive episodes.",
"datePublished": "2022-11-28",
"url": "https://questionsmedicales.fr/article/36455714",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jad.2022.11.047"
}
},
{
"@type": "ScholarlyArticle",
"name": "Rethinking treatment-resistant depression to quasi-tenacious depression.",
"datePublished": "2023-01-12",
"url": "https://questionsmedicales.fr/article/36632817",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1192/j.eurpsy.2022.2353"
}
},
{
"@type": "ScholarlyArticle",
"name": "Viewpoint: Difficult-to-treat depression versus treatment-resistant depression: A new integrative perspective for managing depression.",
"datePublished": "2023-09-08",
"url": "https://questionsmedicales.fr/article/37680180",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1192/j.eurpsy.2023.2448"
}
},
{
"@type": "ScholarlyArticle",
"name": "Innate depression.",
"datePublished": "2022-08-23",
"url": "https://questionsmedicales.fr/article/35998233",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1126/scisignal.ade4885"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Facteurs biologiques",
"item": "https://questionsmedicales.fr/mesh/D001685"
},
{
"@type": "ListItem",
"position": 3,
"name": "Antigènes",
"item": "https://questionsmedicales.fr/mesh/D000941"
},
{
"@type": "ListItem",
"position": 4,
"name": "Superantigènes",
"item": "https://questionsmedicales.fr/mesh/D018089"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Superantigènes - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Superantigènes",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-08",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Superantigènes",
"description": "Comment diagnostique-t-on une infection par superantigènes ?\nQuels tests sont utilisés pour détecter les superantigènes ?\nLes symptômes aident-ils au diagnostic des superantigènes ?\nPeut-on identifier des superantigènes par PCR ?\nLes tests d'allergie sont-ils utiles pour les superantigènes ?",
"url": "https://questionsmedicales.fr/mesh/D018089?mesh_terms=Depression#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Superantigènes",
"description": "Quels sont les symptômes d'une intoxication par superantigènes ?\nLes superantigènes provoquent-ils des douleurs ?\nY a-t-il des symptômes neurologiques associés ?\nLes symptômes varient-ils selon le type de superantigène ?\nLes symptômes sont-ils immédiats après exposition ?",
"url": "https://questionsmedicales.fr/mesh/D018089?mesh_terms=Depression#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Superantigènes",
"description": "Comment prévenir les infections par superantigènes ?\nLes vaccins peuvent-ils prévenir les infections par superantigènes ?\nFaut-il éviter certains aliments pour prévenir les superantigènes ?\nLes mesures d'hygiène sont-elles suffisantes ?\nLes superantigènes peuvent-ils être évités en milieu hospitalier ?",
"url": "https://questionsmedicales.fr/mesh/D018089?mesh_terms=Depression#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Superantigènes",
"description": "Quel est le traitement principal pour les infections par superantigènes ?\nLes corticostéroïdes sont-ils efficaces contre les superantigènes ?\nFaut-il hospitaliser les patients atteints de superantigènes ?\nLes traitements symptomatiques sont-ils recommandés ?\nY a-t-il des traitements spécifiques pour les superantigènes ?",
"url": "https://questionsmedicales.fr/mesh/D018089?mesh_terms=Depression#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Superantigènes",
"description": "Quelles sont les complications possibles des infections par superantigènes ?\nLes superantigènes peuvent-ils causer des lésions organiques ?\nY a-t-il un risque de récidive après une infection par superantigènes ?\nLes complications sont-elles plus fréquentes chez certains patients ?\nLes complications peuvent-elles survenir rapidement ?",
"url": "https://questionsmedicales.fr/mesh/D018089?mesh_terms=Depression#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Superantigènes",
"description": "Quels sont les principaux facteurs de risque pour les infections par superantigènes ?\nLes enfants sont-ils plus à risque d'infections par superantigènes ?\nLes personnes âgées sont-elles à risque accru ?\nLes antécédents d'infections augmentent-ils le risque ?\nLes conditions de vie peuvent-elles influencer le risque ?",
"url": "https://questionsmedicales.fr/mesh/D018089?mesh_terms=Depression#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on une infection par superantigènes ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests sérologiques et l'identification des toxines."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour détecter les superantigènes ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests ELISA et des cultures bactériennes peuvent être utilisés."
}
},
{
"@type": "Question",
"name": "Les symptômes aident-ils au diagnostic des superantigènes ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes cliniques orientent le diagnostic, mais ne sont pas spécifiques."
}
},
{
"@type": "Question",
"name": "Peut-on identifier des superantigènes par PCR ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la PCR peut détecter les gènes codant pour les superantigènes."
}
},
{
"@type": "Question",
"name": "Les tests d'allergie sont-ils utiles pour les superantigènes ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les tests d'allergie ne sont pas pertinents pour les superantigènes."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une intoxication par superantigènes ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fièvre, éruption cutanée, et choc toxique."
}
},
{
"@type": "Question",
"name": "Les superantigènes provoquent-ils des douleurs ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des douleurs musculaires et articulaires peuvent survenir."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes neurologiques associés ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes neurologiques comme des maux de tête peuvent apparaître."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le type de superantigène ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier selon la souche bactérienne impliquée."
}
},
{
"@type": "Question",
"name": "Les symptômes sont-ils immédiats après exposition ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent apparaître rapidement, souvent dans les 24 heures."
}
},
{
"@type": "Question",
"name": "Comment prévenir les infections par superantigènes ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention passe par une bonne hygiène et des pratiques alimentaires sûres."
}
},
{
"@type": "Question",
"name": "Les vaccins peuvent-ils prévenir les infections par superantigènes ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas de vaccins spécifiques contre les superantigènes."
}
},
{
"@type": "Question",
"name": "Faut-il éviter certains aliments pour prévenir les superantigènes ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, éviter les aliments mal cuits ou contaminés peut réduire le risque."
}
},
{
"@type": "Question",
"name": "Les mesures d'hygiène sont-elles suffisantes ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles sont essentielles, mais doivent être combinées avec d'autres pratiques préventives."
}
},
{
"@type": "Question",
"name": "Les superantigènes peuvent-ils être évités en milieu hospitalier ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des protocoles stricts d'hygiène et de désinfection aident à prévenir leur propagation."
}
},
{
"@type": "Question",
"name": "Quel est le traitement principal pour les infections par superantigènes ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement principal est l'administration d'antibiotiques appropriés."
}
},
{
"@type": "Question",
"name": "Les corticostéroïdes sont-ils efficaces contre les superantigènes ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les corticostéroïdes peuvent réduire l'inflammation mais ne traitent pas l'infection."
}
},
{
"@type": "Question",
"name": "Faut-il hospitaliser les patients atteints de superantigènes ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'hospitalisation peut être nécessaire en cas de choc toxique sévère."
}
},
{
"@type": "Question",
"name": "Les traitements symptomatiques sont-ils recommandés ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des traitements symptomatiques comme des antipyrétiques peuvent être utiles."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements spécifiques pour les superantigènes ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas de traitement spécifique ciblant les superantigènes."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles des infections par superantigènes ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent le choc toxique, la défaillance multiviscérale et la septicémie."
}
},
{
"@type": "Question",
"name": "Les superantigènes peuvent-ils causer des lésions organiques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent entraîner des lésions aux reins, au foie et aux poumons."
}
},
{
"@type": "Question",
"name": "Y a-t-il un risque de récidive après une infection par superantigènes ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les infections peuvent récidiver, surtout si les facteurs de risque persistent."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles plus fréquentes chez certains patients ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les patients immunodéprimés sont plus à risque de complications graves."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles survenir rapidement ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines complications peuvent se développer rapidement après l'infection."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque pour les infections par superantigènes ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'immunodépression, les interventions chirurgicales et l'hygiène insuffisante."
}
},
{
"@type": "Question",
"name": "Les enfants sont-ils plus à risque d'infections par superantigènes ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les enfants peuvent être plus vulnérables en raison de leur système immunitaire immature."
}
},
{
"@type": "Question",
"name": "Les personnes âgées sont-elles à risque accru ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées ont un risque accru en raison de la diminution de l'immunité."
}
},
{
"@type": "Question",
"name": "Les antécédents d'infections augmentent-ils le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents d'infections peuvent prédisposer à de nouvelles infections."
}
},
{
"@type": "Question",
"name": "Les conditions de vie peuvent-elles influencer le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des conditions de vie insalubres augmentent le risque d'infections par superantigènes."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 20/03/2025
Contenu vérifié selon les dernières recommandations médicales
6 publications dans cette catégorie
Affiliations :
Department of Computational and Systems Biology, School of Medicine, University of Pittsburgh, Pittsburgh, PA 15261.
6 publications dans cette catégorie
Affiliations :
Department of Pediatrics, Division of Pediatric Infectious Diseases and Immunology, Cedars-Sinai Medical Center, Los Angeles, CA 90048.
Department of Biomedical Sciences, Infectious and Immunologic Diseases Research Center, Cedars-Sinai Medical Center, Los Angeles, CA 90048.
6 publications dans cette catégorie
Affiliations :
Department of Pediatrics, Division of Pediatric Infectious Diseases and Immunology, Cedars-Sinai Medical Center, Los Angeles, CA 90048.
Department of Biomedical Sciences, Infectious and Immunologic Diseases Research Center, Cedars-Sinai Medical Center, Los Angeles, CA 90048.
6 publications dans cette catégorie
Affiliations :
Department of Computational and Systems Biology, School of Medicine, University of Pittsburgh, Pittsburgh, PA 15261.
5 publications dans cette catégorie
Affiliations :
Antibody & Product Development Lab, Experimental Drug Development Centre - Bioinformatics Institute (EDDC-BII), Agency for Science Technology and Research (ASTAR), Singapore, Singapore.
James Cook University, Singapore, Singapore.
Publications dans "Superantigènes" :
5 publications dans cette catégorie
Affiliations :
Department of Pediatrics, Division of Pediatric Infectious Diseases and Immunology, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
Biomedical Sciences, Infectious and Immunologic Diseases Research Center, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
Publications dans "Superantigènes" :
4 publications dans cette catégorie
Affiliations :
Department of Microbiology and Immunology, Schulich School of Medicine & Dentistry, University of Western Ontario, London, Ontario, Canada.
Lawson Health Research Institute, London, Ontario, Canada.
Publications dans "Superantigènes" :
4 publications dans cette catégorie
Affiliations :
Antibody & Product Development Laboratory, Experimental Drug Development Centre-Bioinformatics Institute, Agency for Science, Technology and Research (A*STAR), Singapore 138672, Singapore.
Newcastle Research and Innovation Institute (NewRIIS), Singapore 609607, Singapore.
Publications dans "Superantigènes" :
4 publications dans cette catégorie
Affiliations :
Antibody & Product Development Laboratory, Experimental Drug Development Centre-Bioinformatics Institute, Agency for Science, Technology and Research (A*STAR), Singapore 138672, Singapore.
Publications dans "Superantigènes" :
4 publications dans cette catégorie
Affiliations :
Department of Molecular and Cellular Health Sciences, Graduate School of Pharmaceutical Sciences, Nagoya City University, 3-1 Tanabe-Dori, Mizuho-ku, Nagoya, 467-8603, Japan. Electronic address: s-itoh@phar.nagoya-cu.ac.jp.
Publications dans "Superantigènes" :
4 publications dans cette catégorie
Affiliations :
Department of Molecular and Cellular Health Sciences, Graduate School of Pharmaceutical Sciences, Nagoya City University, 3-1 Tanabe-Dori, Mizuho-ku, Nagoya, 467-8603, Japan.
Publications dans "Superantigènes" :
3 publications dans cette catégorie
Affiliations :
Department of Microbiology and Immunology, Carver College of Medicine, University of Iowa, Iowa City, IA, USA.
Publications dans "Superantigènes" :
3 publications dans cette catégorie
Affiliations :
Bioinformatics Institute, Agency for Science, Technology and Research (A*STAR), Singapore.
Publications dans "Superantigènes" :
3 publications dans cette catégorie
Affiliations :
Bioinformatics Institute, Agency for Science, Technology and Research (A*STAR), Singapore.
Publications dans "Superantigènes" :
3 publications dans cette catégorie
Affiliations :
Bioinformatics Institute, Agency for Science, Technology and Research (A*STAR), Singapore.
Publications dans "Superantigènes" :
3 publications dans cette catégorie
Affiliations :
Institute of Applied Ecology, Chinese Academy of Sciences, Shenyang, China.
Key Laboratory of Superantigen Research, Shenyang Bureau of Science and Technology, Shenyang, China.
Publications dans "Superantigènes" :
3 publications dans cette catégorie
Affiliations :
Institute of Applied Ecology, Chinese Academy of Sciences, Shenyang, China.
Key Laboratory of Superantigen Research, Shenyang Bureau of Science and Technology, Shenyang, China.
Publications dans "Superantigènes" :
3 publications dans cette catégorie
Affiliations :
Institute of Applied Ecology, Chinese Academy of Sciences, Shenyang, China.
Key Laboratory of Superantigen Research, Shenyang Bureau of Science and Technology, Shenyang, China.
Publications dans "Superantigènes" :
3 publications dans cette catégorie
Affiliations :
Institute of Applied Ecology, Chinese Academy of Sciences, Shenyang, China.
Key Laboratory of Superantigen Research, Shenyang Bureau of Science and Technology, Shenyang, China.
Publications dans "Superantigènes" :
2 publications dans cette catégorie
Affiliations :
Protein Engineering Unit, Life and Science Research Department, Anti-Doping Lab-Qatar (ADLQ), Doha, Qatar; Drug Design Group, Department of Pharmacy, University of Groningen, Groningen, the Netherlands.
Publications dans "Superantigènes" :
Lesion locations of post-stroke depression (PSD) mapped to a depression circuit which centered by the left dorsolateral prefrontal cortex (DLPFC). However, it remains unknown whether the compensatory ...
Rs-fMRI data were collected from 82 non-depressed stroke patients (Stroke), 39 PSD patients and 74 healthy controls (HC). We tested the existence of depression circuit, examined PSD-related alteration...
We found that: 1) the left DLPFC showed significantly stronger connectivity to lesions of PSD than Stroke group; 2) in comparison to both Stroke and HC groups, PSD exhibited increased connectivity wit...
Longitudinal studies are required to explore the alterations of depression circuit in PSD as the disease progress....
PSD underwent specific alterations in depression circuit, which may help to establish objective imaging markers for early diagnosis and interventions of the disease....
Mood disturbances have historically remained a core criterion in diagnosing major depressive episode. DSMs have illustrated this criterion with depressed, hopeless, discouraged, cheerless, and irritab...
The current study used a nationally representative sample of U.S. adults with unipolar major depressive disorder to study the association between specific forms of mood disturbances to depression seve...
Cheerless and hopeless mood were associated with depression severity. Hopeless and irritable mood were associated with depression chronicity. Different forms of mood disturbance showed differential re...
The relations between different forms of mood disturbances and various aspects of depression are nuanced. Theoretically, these relations highlight the potential utility in acknowledging the complexity...
With almost one-third of patients with major depression not adequately responsive to treatments, the management of treatment-resistant depression (TRD) has continued to be challenging. Recently, an es...
In the STAR*D study, the efficacy of treatments for major depression was examined. It was found that, while many responded to the initial antidepressant treatment, only 30% of participants achieved co...
Restoring AHI1 in macrophages may improve antiviral immunity in patients with depression....
Depressive disorders encompass a spectrum of diagnoses and are more common in women and transgender individuals. Diagnosis involves thorough history-taking and exclusion of underlying medical disorder...
To review and summarize the literature published between 1 January 2020 and 30 June 2022, on the prevalence, risk factors and impact of depression in transplant population....
Depression is common in transplantation candidates and recipients, with a prevalence up to 85.8% in kidney recipients. Multiple studies have indicated after transplantation depression correlates with ...
Depression is a common finding in transplant population. More research is needed to understand the biological substrate and risk factors and to develop effective treatment interventions....
The goal of this study was to explore the coping strategies of depression sufferers that have worked for them based on the study of an online depression community....
We conducted a thematic narrative analysis of 120 stories posted by the members in the largest online depression community in China. MaxQDA version 18 was used to code the data, and the analytic appro...
The study found that the coping strategies mainly include self-reconciliation (e.g., perceiving/accepting feelings, accepting the present self, and holding hope for the future), actions (recreational ...
The findings revealed the coping strategies that were helpful and examined how they functioned for the affected members, which make up for the lack of attention to the individual experiences of depres...
Evidence-based treatments for adult depression include psychotherapy and pharmacotherapy, yet little is known about how baseline depression severity moderates treatment outcome....
We aimed to compare the effects of psychotherapy and pharmacotherapy for adult depression and to examine the association between baseline depression severity and treatment outcome, converting multiple...
We conducted systematic searches in bibliographical databases up to September 2022 to identify randomized controlled trials (RCTs) in which psychotherapy was compared with pharmacotherapy in the treat...
We identified 65 RCTs including 7250 participants for the meta-analyses and 56 RCTs including 5548 participants for the meta-regression. We found no significant difference between psychotherapy and ph...
Limitations included the low quality of the included studies, and the omission of long-term effects and within-study variability....
We found no indication for a moderation effect of baseline depression severity on the relative effects of psychotherapy and pharmacotherapy. Thus, other factors such as availability and patients' pref...
Depression is a leading cause of disability, affecting approximately 300 million people globally [...]....